ResMed Inc. (0KW4.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 28.19B |
| Enterprise Value | 27.55B |
| P/E Ratio | 22.18 |
| PEG Ratio | 2.38 |
| Price/Sales Ratio | 5.94 |
| Price/Book Ratio | 5.09 |
| Enterprise/Revenue | 5.83 |
| Enterprise/EBITDA | 15.35 |
Fiscal Year
| Fiscal Year | June 30, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.27 |
| Operating Margin | 0.33 |
AD
Management Effectiveness
| Return On Assets | 0.17 |
| Return On Equity | 0.24 |
Income Statement
| Revenue | 5.65B |
| Revenue/Share | 39.07 |
| Gross Profit | 3.41B |
| EBITDA | 2.16B |
| Net Income | 1.52B |
| Diluted EPS | 10.43 |
Balance Sheet
| Total Cash | 1.47B |
| Total Cash/Share | 10.15 |
| Total Debt | 825.92M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 3.1 |
| Book Value Per Share | 45.51 |
Price History
| 52-Week Change | -20.91 |
| 52-Week High | 240 |
| 52-Week Low | 132.67 |
| Moving Average 50 Days | 181.11 |
| Moving Average 200 Days | 176.89 |
Statistics
| Average Volume | 2,991 |
| Shares Outstanding | 142.5M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2.46 |
| Trailing Annual Dividend Yield | 1.06 |
| Payout Ratio | 0.4 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
